| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/24/2007 | CA2628945A1 Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| 05/24/2007 | CA2628928A1 Hepatocyte growth factor intron fusion proteins |
| 05/24/2007 | CA2628332A1 New method for treating cancer based on the modulation of calcineurin |
| 05/24/2007 | CA2627974A1 Methods of treating fibrosing diseases by induction of immune tolerance |
| 05/24/2007 | CA2627370A1 High activity growth factor mutants |
| 05/24/2007 | CA2626728A1 Mntf differentiation and growth of stem cells |
| 05/24/2007 | CA2626522A1 Methods and compositions comprising non-natural amino acids |
| 05/24/2007 | CA2626092A1 Novel highly functional enzyme having modified substrate-specificity |
| 05/24/2007 | CA2626056A1 Interferon in influenza |
| 05/23/2007 | EP1788394A1 Screening for peptides inhibiting PP1c binding to Bcl-2, BCL-Xl and BCL-W proteins |
| 05/23/2007 | EP1788092A1 Method of inhibiting postischemic reperfusion-induced cell death and cell death inhibitor |
| 05/23/2007 | EP1788087A1 Immunogenic detoxified mutant toxins |
| 05/23/2007 | EP1788086A1 Death Domain Containing Receptor 5 |
| 05/23/2007 | EP1788085A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 05/23/2007 | EP1787999A1 Anti-VEGF antibodies |
| 05/23/2007 | EP1787997A1 MU-1, member of the cytokine receptor family |
| 05/23/2007 | EP1787658A1 Sustained release formulations of somatostatin analogue inhibitors of growth hormone |
| 05/23/2007 | EP1787654A1 A method of inducing a CTL response |
| 05/23/2007 | EP1787653A2 Pharmaceutical composition containing polypeptide fragments of serralysins |
| 05/23/2007 | EP1787645A1 New method for treating cancer based on the modulation of the calcineurin and/or the calcineurin/NFAT pathway |
| 05/23/2007 | EP1786902A2 A novel class of therapeutic protein based molecules |
| 05/23/2007 | EP1786835A2 Antiangiogenic compounds, pharmaceutical composition containing said compounds and the use thereof |
| 05/23/2007 | EP1786834A2 Implantable power sources and sensors |
| 05/23/2007 | EP1786833A2 Detection, isolation and uses of renalase (monoamine oxidase c) |
| 05/23/2007 | EP1786787A1 2,4,6-TRIAMINO-S-TRIAZINE-BASED COMPOUNDS WHICH BIND TO THE TAIL (Fc) PORTION OF IMMUNOGLOBULINS AND THEIR USE |
| 05/23/2007 | EP1786463A2 Antibodies against nogo receptor |
| 05/23/2007 | EP1786459A2 Therapeutic composition whit a botulinum neurotoxin |
| 05/23/2007 | EP1786458A2 Y2/y4 selective receptor agonists for therapeutic interventions |
| 05/23/2007 | EP1786457A1 Use of il-6 in vascular complications |
| 05/23/2007 | EP1786456A1 Use of apo2l receptor agonists and nk cells or nk cell activators |
| 05/23/2007 | EP1786455A2 Use of intradiscally administered autologous cells producing type i interferon for the treatment of degenerative disc disease |
| 05/23/2007 | EP1786454A2 Neublastin variants |
| 05/23/2007 | EP1786453A1 Alpha-defensins as anthrax immunotherapeutics |
| 05/23/2007 | EP1786452A1 Use of dm43 and its fragments as matrix metalloproteinases inhibitor |
| 05/23/2007 | EP1786451A2 Anti-angiogenic peptides and methods of use thereof |
| 05/23/2007 | EP1786450A2 Hiv immunostimulatory compositions |
| 05/23/2007 | EP1786449A2 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent |
| 05/23/2007 | EP1786448A1 Use of gsk-3 inhibitors for the treatment of prostate cancer |
| 05/23/2007 | EP1786445A2 Live microbial microbicides |
| 05/23/2007 | EP1786423A1 A pharmaceutical composition for treating ataxia, multiple system atrophy or balance disorders |
| 05/23/2007 | EP1786409A1 Wound healing |
| 05/23/2007 | EP1786400A2 Pharmaceutical compositions for controlled release delivery of biologically active compounds |
| 05/23/2007 | EP1786395A1 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b and other therapeutic proteins |
| 05/23/2007 | EP1786359A1 Medical device for delivering biologically active material |
| 05/23/2007 | EP1594446A4 CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING |
| 05/23/2007 | EP1539800B1 Thrombin peptide derivative dimers |
| 05/23/2007 | EP1539211A4 Method of up-regulating tumor antigen expression using thymalfasin |
| 05/23/2007 | EP1530494B1 A pharmaceutical preparation containing palladium complex compounds |
| 05/23/2007 | EP1519951B1 Cationic linear peptides having antifungal properties |
| 05/23/2007 | EP1385548B1 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 05/23/2007 | EP1308512B1 Novel proteins and dnas thereof |
| 05/23/2007 | EP1272454B1 Method for synthesis of n-[ (s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril |
| 05/23/2007 | EP1265921B1 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 05/23/2007 | EP1253929B1 Use of relaxin to treat diseases related to vasoconstriction |
| 05/23/2007 | EP1223959B1 Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain |
| 05/23/2007 | EP1090146B1 Uses of dna-pk |
| 05/23/2007 | EP1029916B1 Human lysophosphatidic acid receptor and use thereof |
| 05/23/2007 | EP1019074B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 05/23/2007 | EP1015015B1 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY |
| 05/23/2007 | EP0970203B1 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease in humans |
| 05/23/2007 | EP0873407B1 Apo-2 ligand |
| 05/23/2007 | EP0820469B1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 05/23/2007 | CN1969043A ADAMTS-8 proteases and uses thereof |
| 05/23/2007 | CN1969042A Subtilase variants having altered immunogenicity |
| 05/23/2007 | CN1968964A Oligomeric peptides and their use for the treatment of HIV infections |
| 05/23/2007 | CN1968963A Peptide-based compounds |
| 05/23/2007 | CN1968717A Gene delivery system containing relaxin gene and pharmaceutical composition using relaxin |
| 05/23/2007 | CN1968716A Methods of treating lung diseases |
| 05/23/2007 | CN1968710A Stable peptide mimetic of HIV gp41 fusion intermediate |
| 05/23/2007 | CN1968709A VEGF inhibitors for the treatment of malignant pleural effusion |
| 05/23/2007 | CN1968706A Treatment with cisplatin and an EGFR-inhibitor |
| 05/23/2007 | CN1968704A Topical cromolyn formulations |
| 05/23/2007 | CN1968700A Polymer-based sustained release device |
| 05/23/2007 | CN1968695A Compositions comprising immunomodulatory compounds for the treatment and control of myelodysplastic syndromes and using methods |
| 05/23/2007 | CN1968692A Compositions for affecting weight loss |
| 05/23/2007 | CN1968691A Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 05/23/2007 | CN1968678A External preparation for the skin |
| 05/23/2007 | CN1966725A Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 05/23/2007 | CN1966683A Recombinant adenovirus for expression of novel tumour suppressor gene p53 |
| 05/23/2007 | CN1966529A Recombinant toxin agent containing gonadorelin and pyocyanin functional frament |
| 05/23/2007 | CN1966528A PEG-W conjugate linked by urea alkyl bond and its preparation method |
| 05/23/2007 | CN1966527A Polyethylene glycol-interferon coupler and its preparation method |
| 05/23/2007 | CN1966521A Suppressing peptide of heptitis B virus polymerase lymerase protein YMDD functionalized area and its uses |
| 05/23/2007 | CN1966519A Hydrated perindopril salt, preparation method thereof and composition containing the same |
| 05/23/2007 | CN1966517A Earthworm protein EP-2 and its separation method and uses |
| 05/23/2007 | CN1966516A Nanometre collagen oligopeptide and its producing method |
| 05/23/2007 | CN1966073A Medicinal formulation for treating scar |
| 05/23/2007 | CN1966072A Orally administered enteric-coated composition of calcitonin and preparation method thereof |
| 05/23/2007 | CN1966071A Application of edestin in preparation of anti-anoxia functional food |
| 05/23/2007 | CN1966070A Application of edestin in preparation of medicament |
| 05/23/2007 | CN1966069A Application of edestin in preparation of functional food for relieving anemia |
| 05/23/2007 | CN1966068A Transfer factor solution containing cluster water used for animals |
| 05/23/2007 | CN1965865A Pharmaceutical application of macrothele raveni toxin |
| 05/23/2007 | CN1965810A Sustained release microsphere formulation of thymosin alpha-1, preparation process and use thereof |
| 05/23/2007 | CN1965809A Sustained-release microsphere of LHRH antagonist for injection and preparation process thereof |
| 05/23/2007 | CN1317385C Cheese lactobacillus Bd-II strain and use for decreasing blood fat |
| 05/23/2007 | CN1317303C Anti-human tenascin monoclonal antibody |
| 05/23/2007 | CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses |
| 05/23/2007 | CN1317300C Glycine-riched protein and active fragment and use thereof |
| 05/23/2007 | CN1317298C Extraction method and uses of traditional Chinese medicine cassia seed protein |